Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_assertion type Assertion NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_head.
- NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_assertion description "[Given that the identical somatic activating mutation in the JAK2 tyrosine kinase gene (JAK2(V617F)) is observed in most individuals with polycythemia vera, essential thrombocythemia and primary myelofibrosis, there likely are additional genetic events that contribute to the pathogenesis of these phenotypically distinct disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_provenance.
- NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_assertion evidence source_evidence_curated NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_provenance.
- NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_assertion SIO_000772 19287384 NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_provenance.
- NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_assertion wasDerivedFrom ctd_human-20150221 NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_provenance.
- NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_assertion wasGeneratedBy ECO_0000218 NP19951.RA1HRuw2O99TD7Lh8tWVQVUy-h-IwltAgKvc8HPQf50tg130_provenance.